ANA Discussion Forum
General Category => NF2 => Topic started by: Susan A on November 11, 2016, 01:53:59 pm
-
Dr Plotkin at Mass General Hospital is starting a new Phase 2 clinical trial for people with NF2 (http://nfincne.org/17304/nf2-clinical-trial-mgh/). The goal of this clinical research study is to learn if the study drug AZD2014 can shrink growing or symptomatic meningiomas.
-
https://www.nature.com/articles/s41598-020-60156-6